Cargando…
Differential Toxicity of DNA Adducts of Mitomycin C
The clinically used antitumor agent mitomycin C (MC) alkylates DNA upon reductive activation, forming six covalent DNA adducts in this process. This review focuses on differential biological effects of individual adducts in various mammalian cell cultures, observed in the authors' laboratories....
Autores principales: | Bargonetti, Jill, Champeil, Elise, Tomasz, Maria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925095/ https://www.ncbi.nlm.nih.gov/pubmed/20798760 http://dx.doi.org/10.4061/2010/698960 |
Ejemplares similares
-
Repair of mitomycin C mono- and interstrand cross-linked DNA adducts by UvrABC: a new model
por: Weng, Mao-wen, et al.
Publicado: (2010) -
DNA Adducts of Decarbamoyl Mitomycin C Efficiently Kill Cells without Wild-Type p53 Resulting from Proteasome-Mediated Degradation of Checkpoint Protein 1
por: Boamah, Ernest K., et al.
Publicado: (2010) -
Comparative Error-Free
and Error-Prone Translesion
Synthesis of N(2)-2′-Deoxyguanosine
Adducts Formed by Mitomycin C and Its Metabolite, 2,7-Diaminomitosene,
in Human Cells
por: Bose, Arindam, et al.
Publicado: (2016) -
Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21(WAF1/CIP1) activation
por: Cheng, Shu-Yuan, et al.
Publicado: (2016) -
Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction
por: Xiao, Gu, et al.
Publicado: (2015)